Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone

Detalles Bibliográficos
Autores principales: Benguerfi, S., Reizine, F., Eugène, F., Tattevin, P., Maamar, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841007/
https://www.ncbi.nlm.nih.gov/pubmed/35172219
http://dx.doi.org/10.1016/j.idnow.2022.01.008
_version_ 1784650742376693760
author Benguerfi, S.
Reizine, F.
Eugène, F.
Tattevin, P.
Maamar, A.
author_facet Benguerfi, S.
Reizine, F.
Eugène, F.
Tattevin, P.
Maamar, A.
author_sort Benguerfi, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8841007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-88410072022-02-14 Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone Benguerfi, S. Reizine, F. Eugène, F. Tattevin, P. Maamar, A. Infect Dis Now Letter to the Editor Elsevier Masson SAS. 2022-05 2022-02-13 /pmc/articles/PMC8841007/ /pubmed/35172219 http://dx.doi.org/10.1016/j.idnow.2022.01.008 Text en © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Benguerfi, S.
Reizine, F.
Eugène, F.
Tattevin, P.
Maamar, A.
Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title_full Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title_fullStr Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title_full_unstemmed Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title_short Remarkable resolution of COVID-19-associated cerebral vasculitis with methylprednisolone
title_sort remarkable resolution of covid-19-associated cerebral vasculitis with methylprednisolone
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841007/
https://www.ncbi.nlm.nih.gov/pubmed/35172219
http://dx.doi.org/10.1016/j.idnow.2022.01.008
work_keys_str_mv AT benguerfis remarkableresolutionofcovid19associatedcerebralvasculitiswithmethylprednisolone
AT reizinef remarkableresolutionofcovid19associatedcerebralvasculitiswithmethylprednisolone
AT eugenef remarkableresolutionofcovid19associatedcerebralvasculitiswithmethylprednisolone
AT tattevinp remarkableresolutionofcovid19associatedcerebralvasculitiswithmethylprednisolone
AT maamara remarkableresolutionofcovid19associatedcerebralvasculitiswithmethylprednisolone

Ejemplares similares